PERFUSION MEDICAL Trademark

Trademark Overview


On Monday, December 9, 2024, a trademark application was filed for PERFUSION MEDICAL with the United States Patent and Trademark Office. The USPTO has given the PERFUSION MEDICAL trademark a serial number of 98892400. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 9, 2024. This trademark is owned by Perfusion Medical, Inc.. The PERFUSION MEDICAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hemorrhagic shock, acute kidney injury, cardiac shock, and other ischemic conditions

General Information


Serial Number98892400
Word MarkPERFUSION MEDICAL
Filing DateMonday, December 9, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hemorrhagic shock, acute kidney injury, cardiac shock, and other ischemic conditions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePerfusion Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressReston, VA 20190

Trademark Events


Event DateEvent Description
Monday, December 9, 2024NEW APPLICATION ENTERED